WILSON MARTIN (General Counsel) received a stock award from ROCKET PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2026ACC: 0001140361-26-005410
Officer· General Counsel
Since Dec 2021
+780K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
780K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+311.81K
Price / share
—
Trade value
—
% of position
81.2%
2/11/2026
383.82K→695.63K
Total
Net shares
+311.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | A · Award | +311.81K | — | — | 81.2% | 383.82K | 695.63K |
| Total | +311.81K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
468.19K shares
Shares
+468.19K
Strike price
3.24
Held after
468.19K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock468.19K shares | 2/11/2026 | A · Award | +468.19K | 3.24 | — | 468.19K |